Dr. Alipasha Adrangui, MD

Dr. Adrangui practices at Huntington Hospital - Unit in Pasadena, California.

Dr. Adrangui's NPI, 1780911263, was assigned on November 4, 2009. Dr. Adrangui graduated from Azad University in 2002. Dr. Adrangui's California license number on file is A109794.

Dr. Adrangui's primary practice is Huntington Hospital - Unit, at 100 W. California Blvd, Pasadena, CA 91105 in Los Angeles County. The practice phone is (626) 397-2618.

Dr. Adrangui's primary practice is Huntington Hospital - Unit in Pasadena, California. Dr. Adrangui is also affiliated with Huntington Hospital. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Adrangui to 3 more medical groups, 1 physician office, 1 home health agency, 1 hospice, 1 skilled nursing facility and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adrangui practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Adrangui's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Adrangui is board certified in internal medicine by the American Board of Internal Medicine. Dr. Adrangui has a license on file in California.

Dmand AI lists acute diabetes, acute respiratory failure, anemia, bile duct problems, cardiac arrhythmia, chest pain, chest trauma and congestive heart failure among the conditions Dr. Adrangui treats.

CMS data shows 1,197 Medicare services from Dr. Adrangui across 6 procedure codes in 2024, for 352 Medicare patients. Medicare paid $87,754 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 352 Medicare patients who saw Dr. Adrangui in 2024. The largest group is 75 to 84, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 2.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adrangui's median patient age at 66, with 45% women.

In 2024, Dr. Adrangui wrote 618 Medicare Part D claims for 178 patients. 80% of them were for generic drugs. CMS names the drug for 350 of them, across 17 drugs with 11 or more claims each, at $59,300 in total drug cost. In 2023, CMS named 311 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Adrangui for performance year 2024, reported as part of a group. Dr. Adrangui accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 38 general payments to Dr. Adrangui from 12 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $249.

Dr. Adrangui graduated from Azad University in 2002.

Dr. Adrangui is in network with 16 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.